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Background: The current guidelines and evidence supporting acute stroke management have limitations in resource austere environments despite being a leading cause
of death worldwide. Developing countries face a rapidly increasing and disproportionate burden of cerebrovascular disease yet differences in setting and resource lim-
itations bring challenges that have a major inﬂuence in management options – especially with routine imaging and interventional considerations. In addition, general
awareness, diagnosis and management of stroke remain poor.
Objectives: To outline current acute stroke management and critical interventions that should be integrated into current practice while highlighting resource-limited
care considerations.
Methods: A systematic search of Ovid MEDLINE and reference lists of the literature on stroke, guidelines, and acute stroke management including care consider-
ations in resource-limited settings was conducted through March 2014.
Recommendations: Within emergency medicine, emphasis should be placed on establishing a robust stroke assessment and care process that is resource appropriate
and scalable. Adherence as resources allow to current stroke care guidelines including acute management, stroke center coordination, palliation and resource allocation
may improve outcomes. Further research related to resource-limited management is essential. Risk reduction through population-based interventions and early recog-
nition may help to reduce the burden of disease.Contexte: Les lignes directrices et les constatations actuelles sur la prise en charge de l’AVC aigu montrent leurs limites dans les environnements pauvres en ressources,
alors que l’AVC aigu est une cause de mortalite´ majeure dans le monde. Les pays en de´veloppement sont confronte´s a` un fardeau de maladies ce´re´brovasculaires dis-
proportionne´ et en croissance rapide, alors que les diffe´rences de contextes et les ressources limite´es entraıˆnent des difﬁculte´s ayant une inﬂuence majeure sur les pos-
sibilite´s de prise en charge - particulie`rement en termes d’imagerie classique et de possibilite´s d’interventions. De plus, la sensibilisation du public, le diagnostic et la prise
en charge de l’AVC sont toujours largement insufﬁsants.
Objectifs: De´crire la prise en charge et les interventions critiques actuelles associe´es a` l’AVC aigu qui devraient eˆtre inte´gre´es a` la pratique actuelle tout en soulignant
les conside´rations associe´es aux soins dans les contextes pauvres en ressources.
Me´thodes: Une e´tude syste´matique d’Ovid MEDLINE et de publications de re´fe´rence sur l’AVC, les lignes directrices et la prise en charge de l’AVC aigu, et notam-
ment les aspects lie´s aux soins dans des contextes pauvres en ressources, a e´te´ re´alise´e pendant le mois de mars 2014.
Recommandations: En me´decine d’urgence, l’accent doit eˆtre mis sur la mise en place d’une solide proce´dure d’e´valuation et de soins de l’AVC, proportionne´e aux
ressources et e´volutive. L’observance, dans un contexte caracte´rise´ par de faibles ressources, des lignes directrices relatives aux soins de l’AVC, notamment la prise
en charge des cas aigus, la coordination des centres traitant l’AVC, les soins palliatifs et l’allocation des ressources, peut ame´liorer les re´sultats. Il est essentiel de pour-
suivre la recherche sur la prise en charge avec des ressources limite´es. La re´duction du risque par des interventions au sein de la population et un de´pistage pre´coce peut
contribuer a` atte´nuer le fardeau de la maladie.African relevance
 Ensure early assessment and stabilization of ABCs in acute
stroke management. Stroke mimics, such as hypoglycemia, should be promptly
assessed.
 Blood pressure management is essential and depends on the
type of stroke.
 Establish a stroke protocol following evidence-based,
resource allowable practices.Introduction
Nearly 60% of all deaths worldwide are associated with
chronic diseases, such as heart disease, stroke, and cancer.1
38 B. Nicks et al.Stroke, the second leading cause of death, accounted for 5.7
million deaths in 2005. The vast majority (>85%) of these
deaths occur in low and middle income countries with one
third under the age of 70.2,3 Cerebrovascular disease is perva-
sive and rapidly expanding, affecting the poor and disadvan-
taged disproportionately, furthering health gaps within and
between countries.4
A study done in sub-Saharan Africa (SSA) shows that the
trend of stroke is increasing in young populations, however
much of the public health focus remains on infectious and
communicable diseases.5 Similar to developed countries, high
blood pressure remains a major determinant for stroke and
subsequent death.6 While stroke risk is increasing by rapid
urbanization and transition from agrarian to urban determi-
nants, awareness, diagnosis and management of stroke remain
limited.5,6
Current models of care for acute neurologic emergencies
are time sensitive and resource dependent. Established global
guidelines require prompt recognition of symptoms, immediate
transportation to an emergency center, emergent brain imag-
ing, laboratory testing, and prompt thrombolytic interventions
when appropriate. Stroke guidelines primarily emanate from
developed systems with comprehensive stroke services limiting
uniform adoption in less austere settings. Minimizing brain
injury, managing comorbid illness and complications while
uncovering the causative etiology are paramount for quality
outcomes.
This manuscript will address optimal care ﬁrst, then
resource-limited considerations recognizing research limita-
tions in many areas. Establishing a standardized, scalable
and affordable mode of evaluation, transportation and man-
agement of acute stroke patients as well as standard prevention
and rehabilitation protocols that will help to reduce stroke
occurrence, mortality and morbidity to the population are
essential regardless of resource limitations.
Source of data
A systematic search of Ovid MEDLINE and reference lists on
stroke literature, guidelines, and acute stroke management
including resource-limited settings was conducted through
March 2014.
Acute stroke management
Acute focal brain function deﬁcit is a central feature of acute
ischemic stroke (AIS). Early recognition and transportation
to a care center is paramount and allows prompt assessment,
stabilization, laboratory and radiography evaluations. CriticalTable 1 Differential diagnoses for acute ischemic stroke.
Complex migraine
Syncope
Systemic/central infection
Functional deﬁcit (conversion disorder)
Head trauma/subdural
Transient global amnesia
Multiple sclerosis exacerbationdecisions based on these ﬁndings may require secondary
interventions such as intubation, blood pressure control,
thrombolytic considerations, and comorbid management.7–11
Patients suffering an acute neurologic event (ANE) may have
concurrent serious medical conditions. Therefore, a rapid but
thorough assessment should include:
 ABCs Assessment (Airway, breathing and circulation)
and other emergent medical interventions.
 Immediate identiﬁcation and treatment of any contrib-
uting medical conditions (e.g., hypoglycemia, hypoten-
sion and hypoxia) (Table 1).
 Thrombolytic therapy determination for acute ischemic
stroke (Table 2).
 Identifying the cause of the patient’s acute neurologic
presentation.
As time from onset to intervention is of paramount impor-
tance, the initial evaluation of stroke patients will determine
interventions. Obtaining a history, physical examination,
serum glucose, oxygen saturation, and a non-contrast CT scan
are sufﬁcient in most cases to identify potential candidates for
thrombolytics. Critical information includes the time of symp-
tom onset along with speciﬁc aspects of the past medical his-
tory that may affect the use of thrombolytics.
Critical interventions
ABCs
Assessing vital signs and ensuring stabilization of airway,
breathing, and circulation are fundamental to all critical
patients, including those with stroke. We recall that acute
stroke from intracranial hemorrhage, vertebrobasilar, or
bihemispheric ischemia can cause elevated intracranial pres-
sure causing decreased respiratory drive or inability to protect
the airway. Cerebral vasodilation from hypoventilation and
resulting hypercarbia may further increase intracranial pres-
sure and therefore perpetuate a cycle leading to respiratory
failure. Supplemental oxygen has not been shown to be bene-
ﬁcial in non-hypoxic stroke victims and should only be pro-
vided for hypoxic patients.8,9,12
Initial history & physical (H&P)
Establishing the ischemic stroke onset time is critical because it
is the main eligibility determinant for treatment with intrave-
nous thrombolysis. For patients who are unable to provide a
reliable onset time, use the last known normal time. For thosePosterior Reversible Encephalopathy Syndrome (PRES)
Encephalopathy (hypertension, infectious, Wernicke)
Seizure with postictal paresis, aphasia or neglect
Spinal cord disorder (compressive myelopathy, etc)
Central Nervous System Tumor or Abscess
Metabolic derangement (hypoglycemia, toxins, etc)
Table 2 Criteria for rTPA Treatment in acute ischemic stroke.
Inclusion criteria
Clinical diagnosis of ischemic stroke causing measurable neurologic deﬁcit
Onset of symptoms <4.5 h before onset of treatment; use the last known normal time if uncertain
Age 18 or older
Exclusion criteria
Signiﬁcant stroke or head trauma within 3 months
Previous intracranial hemorrhage
Intracranial neoplasm, arteriovenous malformation or aneurysm
Recent intracranial or intraspinal surgery
Arterial puncture at a noncompressible site within 1 week
Concern for/symptoms of subarachnoid hemorrhage
Persistent blood pressure elevation (>185 mmHg SBP or >110 mmHg DBP)
Serum glucose < 2.8 mmol/L (<50 mg/dL)
Active internal bleeding
Acute bleeding diathesis
Platelet count < 100,000/mm3
Anticoagulant use with INR> 1.7 or PT > 15 s
Heparin use within 48 h and elevated aPTT
Use of a direct thrombin inhibitor or factor Xa inhibitor with lab evidence of anticoagulant eﬀect
Head CT evidence of hemorrhage
Evidence of multilobar infarction with >33% hypodensity of the cerebral hemisphere
Relative exclusion criteria
Minor or isolated neurologic signs
Spontaneous clearing of stroke symptoms
Major trauma or surgery within 2 weeks
GI or GU bleeding within 3 weeks
Myocardial infarction in the past 3 months
Seizure at the onset of stroke with postictal impairments
Pregnancy
Treatment from 3 to 4.5 h from onset relative exclusions
Age > 80 years
Oral anticoagulant use
Severe stroke (NIHSS > 25)
History of ischemic stroke and diabetes mellitus
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identifying thrombolytic contraindications is essential. The
H&P should be used to differentiate between other stroke
mimics, such as seizures, syncope, migraine, central infection,
hypoglycemia or drug toxicity.11
Acute, severe headache and vomiting at onset favor sub-
arachnoid (SAH) or intracerebral hemorrhage ICH compared
with a thromboembolic stroke. SAH is also more likely to
present with acute onset of cerebral dysfunction without focal
symptoms. However, clinical diagnosis of intracranial hemor-
rhage is very imprecise, so early CT imaging is critical.13
A thorough physical exam should include a speciﬁc focus
on vascular abnormalities (e.g., bruits, pulse abnormalities,
cardiac features, and signs of endocarditis), degree of neuro-
logic deﬁcits (including changes over time), and signs of sec-
ondary medical concerns (e.g., tongue lacerations, trauma,
recent surgery). For evidence of head trauma or fall suspicion,
appropriate head and cervical spine imaging and immobiliza-
tion should be obtained.
Neurologic evaluation
This examination provides quantiﬁable information related to
the involved vascular territories and the severity of stroke. The
National Institutes of Health Stroke Scale (NIHSS), validatedand widely accepted, is composed of 11 items with a range
from 0 to 42 points. As the admission NIHSS score correlates
with stroke outcome, it often serves as a basis for outcome dis-
cussion with patients and family.11–14
Investigations
The following studies should be emergently considered for sus-
pected stroke patients (within resource constraints):
 Noncontrast brain CT (or MRI) in settings where
resources are not limited: Imaging studies are essential
to rule out hemorrhage as a cause of the acute deﬁcit.
They may further identify the responsible vascular
lesion requiring possible intervention. Advanced CT
and MRI methods can deﬁne the potentially salvage-
able ischemic penumbra – and may assist in identifying
those patients who may beneﬁt from therapy and pre-
dict outcomes.
 Serum glucose (bedside testing recommended): Hypo-
glycemia is not an uncommon stroke mimic that can
be rapidly corrected.
 Oxygen saturation: Hypoxia needs to be addressed
emergently – recognizing that it may be caused by the
stroke or associated with a secondary medical issue.
40 B. Nicks et al.Other immediate tests for the evaluation of ischemic and
hemorrhagic stroke include the following:
 Electrocardiogram: Electrocardiography (ECG) is
important for identifying rhythm abnormalities and
possible concomitant cardiac ischemia. In stroke, the
secondary sympathetic response may create demand-
induced cardiac ischemia, especially in at-risk individu-
als. Centrally mediated ECG changes can be seen in
large strokes (e.g., large subarachnoid hemorrhage).
Cardiac monitoring for the ﬁrst 24 h after ischemic
stroke onset monitoring for atrial ﬂutter or ﬁbrillation
(AF) is recommended.8
 Complete blood count including platelets: If a hemor-
rhagic stroke is diagnosed, platelets may need to be
transfused if the patient is thrombocytopenic. Evidence
for this practice is limited but it is recommended by
current AHA/ASA guidelines.8
 Basic metabolic panel: Abnormalities in sodium and
blood urea nitrogen can lead to altered mental status
and are easily reversible problems.
 Coagulation studies: If a patient is on anticoagulant
therapy, an intracranial hemorrhage would require
emergent reversal with vitamin K, fresh frozen plasma,
or prothrombin-complex concentrate depending on
medication and availability.
Acute stroke management
Thrombolytics
While there is ongoing debate related to the literature sup-
porting thrombolytic use and timing, current guidelines sug-
gest that eligible AIS patients (Table 2) receive intravenous
alteplase therapy, when started within 3 h of accurate symp-
tom onset. For patients who cannot be treated in less than
3 h, intravenous alteplase therapy has been suggested, if
treatment is started within 3–4.5 h of accurate symptom
onset.8
Fluids
Intravascular volume depletion is frequent with acute stroke,
particularly in the elderly, and may worsen cerebral blood
ﬂow.15 For most patients with acute stroke and volume deple-
tion, isotonic saline without dextrose is the agent of choice for
intravascular ﬂuid repletion and maintenance therapy.15 In
general, it is best to avoid excess free water because hypotonic
ﬂuids may exacerbate cerebral edema in acute stroke. In addi-
tion, it is best to avoid ﬂuids containing glucose, which may
exacerbate hyperglycemia.
Hypoglycemia
Focal deﬁcits and neuronal injury, mimicking stroke, can be
caused by hypoglycemia. Rapid evaluation and correction
of a low blood glucose level (<60 mg/dL or 3.3 mmol/L)
is essential – with normoglycemia being the desired
goal.16Hyperglycemia
Elevated glucose (glucose level >126 mg/dL or >7.0 mmol/L)
is associated with poor outcomes in stroke. The AHA/ASA
and European Stroke Initiative guidelines recommend
treatment for glucose >180 mg/dL (>10 mmol/L) while
aiming for concentrations in the range of 140–180 mg/dL
(7.8–10 mmol/L).17–22
The SHINE trial (NINDS-funded RCT) is evaluating the
impact of tight control of glucose with intravenous insulin in
AIS.23,24 In 2011, a systematic review identiﬁed no difference
between the control or treatment groups for combined out-
comes of dependence, disability, death, or ﬁnal neurologic
deﬁcit.25
Swallowing assessment
Aspiration, associated with dysphagia, is a common cause of
pneumonia and increases associated morbidity and/or mortal-
ity in stroke patients. Performing swallowing assessments
before providing oral medications or food is essential in all
stroke patients.26
Head and body position
During the acute process, positioning and head-of-bed eleva-
tion should be patient speciﬁc considering aspiration and
increased ICP risk.26–29 Ensure the head-of-bed is at 30 degrees
with the head in neutral alignment for acute stroke patients at
risk for the following:
 Increased ICP.
 Aspiration (Altered level of consciousness, dysphagia,
or failed screening).
 Cardiorespiratory decompensation or hypoxia.Fever
Although fever is typically associated with an infectious pro-
cess, it may also be a central response to an ischemic or hem-
orrhagic stroke from resultant autonomic dysfunction.
Nevertheless, a fever should prompt a full infectious workup
keeping in mind the possibility of stroke mimic. If fever is
deemed secondary to stroke, neurologic injury may be exacer-
bated by fever and according to animal models may worsen
cerebral ischemia.30–32 Therefore, source control and antipy-
retic management is of paramount importance.33–37
Anticoagulation reversal in hemorrhagic strokes
For intracerebral bleeds in patients on anticoagulation, man-
agement options are speciﬁc to the anticoagulant and may
include vitamin K, recombinant factor concentrates and fresh
frozen plasma.
 Vitamin K antagonists (e.g., warfarin): Current recom-
mendations for the reversal of warfarin include vitamin
K and four-factor concentrate. If four-factor concen-
trate is not available, then fresh frozen plasma will be
needed for reversal.
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limited, but suggestions for reversal include drug dis-
continuation, dialysis, activated charcoal to bind any
unabsorbed drug from the GI tract, and 3- or 4-factor
concentrates.54
 Factor Xa inhibitors (e.g., rivaroxaban, apixaban):
Data are limited, but suggestions for reversal include
drug discontinuation, charcoal hemoﬁltration, acti-
vated charcoal, and the use of unactivated or activated
PCCs (prothrombin complex concentrates). Both riva-
roxaban and apixaban are highly protein bound and
therefore not amenable to removal by dialysis.54
Blood pressure (BP) management
In patients with AIS, the acutely elevated blood pressure is con-
sidered necessary for brain perfusion, especially in areas distal
to the obstructed vessel. This elevated pressure may also reﬂect
a sympathetic response, chronic hypertension, or additional
stroke associated mechanisms.38–42 While there is long-term
beneﬁt from antihypertensive therapy, lowering AIS patients’
blood pressure acutely has been associated with clinical
compromise and poor neurologic outcome.43–50
BP management in ischemic stroke
For AIS patients not receiving thrombolytics, consensus guide-
lines recommendations state blood pressure should not be
acutely treated except for extreme hypertension (>220 mmHg
or DBP > 120 mmHg for systolic and diastolic BP, respec-
tively), or secondary conditions such as acute coronary ische-
mia, acute renal failure, heart failure, dissection,
encephalopathy, or acute renal failure. When indicated, lower-
ing of BP by approximately 15 percent is suggested.41–45 Current
guidelines suggest that, unless otherwise contraindicated and
neurologically stable, restarting a patient’s blood pressure
medications about 24 h after stroke onset may be ideal.48–50Figure 1 ROSIER scoring system. A ROSIER score of one or mo
unlikely but not completely excludedFor thrombolytic therapy, blood pressure control
(6185 mmHg and 6110 mmHg for systolic and diastolic BP,
respectively) is recommended. Stabilization and maintenance
at or below 180/105 mmHg for 24 h or longer after thrombo-
lytics may minimize the likelihood of post-lytic ICH.41–45
BP management in hemorrhagic stroke
Balancing the risk of reducing cerebral perfusion pressure ver-
sus possible bleed reduction is essential for hemorrhagic stroke
blood pressure management. Blood pressure reduction may
minimize further vascular injury and continued bleeding for
those with SAH or ICH. Literature supports a systolic BP of
160–140 mmHg as an acceptable goal.50–53
Antihypertensive selection
No deﬁnitive evidence exists to support any speciﬁc antihyper-
tensive agent to achieve recommended BP goals in acute
stroke. Consensus guidelines suggest intravenous labetalol
and nicardipine as ﬁrst-line antihypertensive agents as they
allow rapid and safe titration to the goal BP. Intravenous
nitroprusside, a second-line consideration, has theoretical risks
of increasing intracranial pressure and possibly decreasing
platelet function – both unwanted side effects. Avoidance of
medications with either a prolonged or rapid decline in blood
pressure is essential as they have an increased associated risk of
stroke proliferation, particularly in elderly patients.46–50
Stroke unit care
Mounting evidence suggests that patients with acute stroke
have better outcomes when admitted to a hospital unit that
is specialized for the care of patients with all types of acute
stroke. Components include prompt availability of neuroimag-
ing (e.g., CT, MRI, angiography, ultrasound, transcranial
Doppler) and cardiac imaging. Studies have demonstrated
implementation of stroke protocols and disease-performancere suggests a stroke. A score of zero or less indicates a stroke is
42 B. Nicks et al.measures may contribute to improved outcomes and decreased
risk of stroke-related complications.55–60 However, adherence
to stroke center protocols, including appropriate palliative
care and rehabilitation resources, even at non-stroke special-
ized centers may improve quality as well.61
Stroke management in resource limited settings
In a resource limited setting, management may be guided by
alternative diagnostic measures depending on what is available
at a given location. In most circumstances, the recommenda-
tions below identify areas where more research is required.
No advanced imaging available
If a CT scanner is not available, there is no other reliable indi-
cator differentiating an ischemic versus a hemorrhagic stroke
based on other elements of the history, physical, or laboratory
workup.62,63 Differentiation between acute stroke and stroke
mimics can be effectively triaged using the ROSIER scale
and may prove instrumental for referrals (Fig. 1).64 However,
in the absence of imaging, application of a protocol to address
critical interventions, evaluations, and management is essential
– and may include transfer to an appropriate facility. Throm-
bolytics should not be utilized if a hemorrhagic stroke or mass
cannot be ruled out.
No antihypertensive medication available
In the absence of any IV antihypertensive medications, benzo-
diazepines may be utilized to decrease the sympathomimetic
response to the stroke based on the GABA-agonist mechanism
of them. Care must be taken as these will decrease the respira-
tory rate (hypercapnea) in the patient. They should also be
used judiciously with the elderly since they may contribute to
delirium and hence, mortality.
No thrombolytics available
Without thrombolytics, this treatment (and secondary preven-
tion) would revert to antiplatelet therapy (aspirin 160–325 mg
daily), which may reduce the risk of early ischemic stroke with-
out major risk of early hemorrhagic complications.65,66 Qual-
ity outcomes will vary greatly in such settings based on the
availability of coordinated stroke care services and associated
care management.67,68 Dual anti-platelet therapy, such as aspi-
rin in addition to clopidogrel, has not yet been established as
standard of care in acute stroke and is therefore not recom-
mended (AHA/ASA Guidelines).8 Other antithrombotics such
as heparin and low molecular weight heparin are not recom-
mended based on the current literature in acute ischemic
stroke.69–71
No stroke unit available
The severity of the stroke and the need for additional
resources, such as specialized rehabilitation (speech, swallow-
ing, PT/OT, etc.) should guide the decision to transfer. In
the case of utilizing thrombolytics, the need for continued
BP control, or interventional management, transfer may beessential. Consideration for telemedicine consultations or
transfer protocols to the nearest stroke center may provide
value.
No reversal agents available
All agents will reverse with time (based on metabolism and
half-life), so transfer may not be feasible or indicated. Platelets
may be given, but without the lattice for the platelets to
adhere, there is no evidence that this will beneﬁt a patient on
warfarin or factor Xa inhibitors. Current AHA/ASA guide-
lines give platelet transfusion a class 1 level of evidence C rec-
ommendation in patients with severe thrombocytopenia.8,68 A
recent literature review article did not ﬁnd evidence supporting
any change in mortality with platelet transfusion in the man-
agement of acute hemorrhagic stroke in patients on anti-plate-
let therapy, although evidence is limited.72
Consideration for palliative care
In some cases involving severe stroke or speciﬁc disabilities
(inability to swallow), it may be in the best interest of the
patient, family and the community to discuss palliative care
options. Cultural integration and creating a supportive envi-
ronment is paramount with any such program.67,68 Prognosti-
cation in acute stroke victims is difﬁcult, but there are some
clinical scoring systems (such as the modiﬁed Rankin scale)68
that allow the clinician to objectively determine the degree of
disability and therefore the long-term requirements that the
patient may need. These requirements may include tracheos-
tomy, surgical gastric tube placement, long-term skilled nurs-
ing care, etc. Depending on those needs, it may not be
feasible in a resource-limited setting.Summary
The fundamental goals for acute stroke care include medical
stability, identiﬁcation of thrombolytic candidates (if utilized),
identiﬁcation and reversal of contributing conditions, and a
coordinated transition of care to a multidisciplinary stroke
team to further identify the pathophysiologic basis of the neu-
rologic symptoms. While further research is required to deﬁne
evidence-based outcomes when resources are limited, the fol-
lowing represent foundational essentials for acute stroke eval-
uation and care based on current best practices and should
serve as a template for optimal care based on available
resources:
 Ensuring stabilization of the ABCs.
 Prompt but accurate H&P to reﬁne the differential
diagnosis of acute neurologic emergencies, speciﬁcally
screening for stroke mimics or other reversible
pathology.
 Obtaining emergent brain imaging and other important
laboratory studies. If no imaging modality is available,
recommendations are limited to supportive care and
transfer if possible.
 Lytic intervention when indicated. If none available,
early aspirin therapy for secondary prevention should
be implemented if the stroke is ischemic.
Neurologic emergencies in resource-limited settings 43 Managing electrolyte disturbances while maintaining
euvolemia and euglycemia.
 Assess swallowing and implement aspiration preven-
tion including head of bed positioning.
 Blood pressure management depending on the type of
stroke.
 Consider infectious sources of fever and work to main-
tain normothermia using methods such as antipyretics
and external cooling.
 Establish a ‘stroke protocol’ following the best evi-
dence-based practices, resources available and coordi-
nated with the nearest stroke center.
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